The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Amgen Inc. (AMGN), Thermo Fisher ...

Last Friday, the three benchmark Wall Street indexes closed a losing week. The S&P 500 fell 1.43%, the Nasdaq declined 2.05% ...

The biotech raised its full-year revenue forecast to $38.2 billion–$39.4 billion after second-quarter revenue rose 10% to $10.1 billion ...

Elaine’s stories explore the boom in new obesity treatments, new drug payment models, the ways companies are affected by FDA changes, and the emerging psychedelics drug sector. She co-writes The ...

Amgen Inc. experienced a cyber incident that involved the theft of patient information and proprietary data stored in cloud servers, it said in a filing Friday, the latest large healthcare company to ...

Amgen is entering a pivotal period the as it moves beyond its Enbrel franchise and repositions around obesity, rare disease and next-generation oncology. While Enbrel has entered a period of decline ...

TScan has told Fierce that its pipeline strategy remains unchanged despite Amgen walking away from a Crohn’s disease ...

FTC challenges Amgen's Enbrel patent strategy, the long, winding path for the Moderna-Merck cancer vaccine, and more biotech ...

Amgen Inc () has held its Q2 earnings call. Read on for the main highlights of the call. Claim 55% Off TipRanks. Unlock powerful investing tools with TipRanks Premium to make smar ...

Amgen said on Friday it submitted new evidence to the FDA on July 23 ​as it seeks a hearing to challenge the proposed ‌withdrawal of its rare-disease drug Tavneos from the U.S. market.

Amgen Inc. experienced a cyber incident that involved the theft of patient information and proprietary data stored in cloud servers, it said in a filing Friday, the latest large healthcare company to ...